143 related articles for article (PubMed ID: 33164541)
1. The impact of propranolol on apoptosis in cutaneous squamous cell carcinomas.
Celik E; Kaplan HM; Singirik E
Bratisl Lek Listy; 2020; 121(11):801-804. PubMed ID: 33164541
[TBL] [Abstract][Full Text] [Related]
2. Effects of photodynamic therapy using Red LED-light combined with hypocrellin B on apoptotic signaling in cutaneous squamous cell carcinoma A431 cells.
Liu Y; Cao Z; Wei G
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103683. PubMed ID: 37390854
[TBL] [Abstract][Full Text] [Related]
3. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
5. GRIM-19 represses the proliferation and invasion of cutaneous squamous cell carcinoma cells associated with downregulation of STAT3 signaling.
Wu N; Hui H; Cui L; Yang F
Biomed Pharmacother; 2017 Nov; 95():1169-1176. PubMed ID: 28926927
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
[TBL] [Abstract][Full Text] [Related]
7. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of LINC00319 indicates a poor prognosis and promotes cell proliferation and invasion in cutaneous squamous cell carcinoma.
Li F; Liao J; Duan X; He Y; Liao Y
J Cell Biochem; 2018 Dec; 119(12):10393-10405. PubMed ID: 30145798
[TBL] [Abstract][Full Text] [Related]
9. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
10. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
11. NR5A2 promotes malignancy progression and mediates the effect of cisplatin in cutaneous squamous cell carcinoma.
Ye W; Ya-Xuan C; Shan-Shan T; Qiu L; Ting M; Shao-Jie C; Yu C
Immun Inflamm Dis; 2024 Feb; 12(2):e1172. PubMed ID: 38358044
[TBL] [Abstract][Full Text] [Related]
12. Loss of BAX by miR-365 Promotes Cutaneous Squamous Cell Carcinoma Progression by Suppressing Apoptosis.
Zhou L; Gao R; Wang Y; Zhou M; Ding Z
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28556798
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.
Chen W; Leiter A; Yin D; Meiring M; Louw VJ; Koeffler HP
Int J Oncol; 2010 Sep; 37(3):737-43. PubMed ID: 20664943
[TBL] [Abstract][Full Text] [Related]
14. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
[TBL] [Abstract][Full Text] [Related]
15. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.
Quadri M; Tiso N; Musmeci F; Morasso MI; Brooks SR; Bonetti LR; Panini R; Lotti R; Marconi A; Pincelli C; Palazzo E
J Exp Clin Cancer Res; 2023 Jul; 42(1):167. PubMed ID: 37443031
[TBL] [Abstract][Full Text] [Related]
16. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.
Hsu CY; Yanagi T; Maeda T; Nishihara H; Miyamoto K; Kitamura S; Tokuchi K; Ujiie H
Sci Rep; 2023 May; 13(1):8650. PubMed ID: 37244956
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-142-5p induces cancer stem cell-like properties of cutaneous squamous cell carcinoma via inhibiting PTEN.
Bai X; Zhou Y; Chen P; Yang M; Xu J
J Cell Biochem; 2018 Feb; 119(2):2179-2188. PubMed ID: 28857248
[TBL] [Abstract][Full Text] [Related]
18. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
19. MiR-1193 was sponged by LINC00963 and inhibited cutaneous squamous cell carcinoma progression by targeting SOX4.
Wang J; Li C; Xu L; Yang C; Zhang X
Pathol Res Pract; 2019 Oct; 215(10):152600. PubMed ID: 31477326
[TBL] [Abstract][Full Text] [Related]
20. Cold atmospheric plasma attenuates skin cancer via ROS induced apoptosis.
Liu C; Zha J; Sun T; Kong L; Zhang X; Wang D; Ni G
Mol Biol Rep; 2024 Apr; 51(1):518. PubMed ID: 38622261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
